Ryght is an innovative company leveraging generative AI platforms to revolutionize clinical trial site selection and feasibility processes. They offer AI Site Twins, which are digital replicas of every clinical research site worldwide, providing predictive capabilities to enhance site selection, feasibility, and study optimization throughout clinical trials.

Ryght aims to supercharge site selection and study feasibility with AI-powered technology that rapidly analyzes protocols and connects sponsors and CROs with high-potential research sites globally. Their technology streamlines site selection, accelerates site activation, and optimizes site performance for the duration of the trial. Ryght's platform is available on the Microsoft Azure Marketplace, increasing cost efficiency and simplifying billing for customers.